Skip to main content

Beyond Antibiotics

EIN: 83-1983463Danville, CAZIP: 94526
H05 - Medical Research501(c)(3)

Mission

Beyond Antibiotics is dedicated to advancing research in the area of compounds, such as antimicrobial or antimicrobial-like substances, and other efforts that prevent and protect against infectious diseases and improve overall human and animal health.

Financials

YearRevenueExpensesAssets
2023$350k$0$328k

Compensation

William E Brown
$0
$0
$0
$0
Jill DeMichiel
$0
$0
$0
$0
Sharon Bonner-Brown
$0
$0
$0
$0

Similar Organizations

$326k revenue
Similar sector (H)Very similar revenue ($326k vs $350k)Same state (California)Similar size (2 vs 3 executives)
$319k revenue
Similar sector (H)Very similar revenue ($319k vs $350k)Same state (California)Similar size (1 vs 3 executives)
$373k revenue
Similar sector (H)Very similar revenue ($373k vs $350k)Same state (California)Similar size (2 vs 3 executives)
$324k revenue
Similar sector (H)Very similar revenue ($324k vs $350k)Same state (California)Similar size (1 vs 3 executives)
Cruisin For a Cure

Mission Viejo, CA

$322k revenue
Similar sector (H)Very similar revenue ($322k vs $350k)Same state (California)Similar size (3 vs 3 executives)
$369k revenue
Similar sector (H)Very similar revenue ($369k vs $350k)Same state (California)Similar size (3 vs 3 executives)
THE SPINE INSTITUTE FOUNDATION

Westlake Village, CA

$342k revenue
Similar sector (H)Very similar revenue ($342k vs $350k)Same state (California)Similar size (1 vs 3 executives)
Attune Health Foundation

Beverly Hills, CA

$222k revenue
Same sector (H05)Comparable revenue ($222k vs $350k)Same state (California)Similar size (3 vs 3 executives)
BCS FOUNDATION

Lake Forest, CA

$379k revenue
Similar sector (H)Very similar revenue ($379k vs $350k)Same state (California)Similar size (3 vs 3 executives)
THE TUMORI FOUNDATION

San Francisco, CA

$381k revenue
Similar sector (H)Very similar revenue ($381k vs $350k)Same state (California)Similar size (5 vs 3 executives)
Data from IRS Form 990 filings (2023).